Dr. Hiroyuki Yamamoto from the Department of Cardiovascular Medicine at Narita-Tomisato Tokushukai Hospital in Chiba, Japan, led the following team of people in determining the cause behind the global spike in cardiac deaths that occurred after Operation Warp Speed was launched:
- Katsuya Hashimoto, Department of Cardiovascular Medicine, Narita-Tomisato Tokushukai Hospital, Chiba, Japan.
- Yoshihiko Ikeda, Department of Pathology, National Cerebral and Cardiovascular Center, Suita, Japan.
- Jun Isogai, Department of Radiology, Asahi General Hospital, Asahi, Japan.
- Toru Hashimoto, Katsuya Hashimoto, Department of Cardiovascular Medicine, Narita-Tomisato Tokushukai Hospital, Chiba, Japan.
This powerful team of scientific experts produced evidence showing that COVID injections cause vaccine-induced myocarditis, also known as VAM. If left untreated, VAM can kill a person.
The problem is that diagnosing VAM is difficult. The condition is compared to a ticking time bomb that only makes its presence known after a potentially deadly heart attack.
(Related: A recent study found that 70 percent of Pfizer COVID jab deaths in Japan were reported within 10 days of injection.)
Vaccine-induced myocarditis (VAM) a ticking time bomb
In a paper they published in the journal ESC Heart Failure, Yamamoto and his team explained why VAM is difficult to diagnose early. Minor focal myocarditis, multisystemic inflammatory syndrome, and fulminant myocarditis are among the many phenotypes and pathophysiology associated with VAM that further complicate trying to identify and deal with it early.
Yamamoto and his team admit that there is still so much that science does not know about how COVID injections, and especially the mRNA (modRNA) variety, cause such serious problems in the heart. They write that "histological evaluation remains to be fully understood."
In their paper, Yamamoto and his team feature the case report of a 78-year-old formerly healthy female athlete who was referred to her family physician after developing dyspnea just 11 days after taking a third COVID shot, Moderna's mRNA-1273 "booster." Before getting vaccinated with Moderna's COVID-19 booster, the woman took the two-dose primary series of BNT162b2 from Pfizer and BioNTech.
For days after getting jabbed with Moderna, the woman "experienced palpitations and dyspnea, which gradually worsened." She reported no recent travel history as well as a history of mild dementia, but no risk factors for coronary artery disease were uncovered.
The woman basically had a clean bill of health with no contact with COVID patients and no history of alcohol, cigarette, or illicit drug use. Why, then, did her heart fail if not because of the COVID injections she received in order to "stop the spread?"
The type of biopsy the team conducted is known as endomyocardial, the only known kind that is capable of identifying VAM. Biopsy-proven dilated cardiomyopathy (DCM) was identified along with a pathological diagnosis of chronic myocarditis and inflammatory cardiomyopathy (iDCM).
The case outlined in the study marks the first time that iDCM was proven through biopsy in relation to heterologous mRNA-1273 "immunization."
The female patient in question was successfully treated with corticosteroids, based on the biopsy results. In the end, her life was saved by what Yamamoto and his team learned through their experiments.
Yamamoto et al. are now calling on clinicians around the world to perform endomyocardial biopsies on all patients who present with the DCM phenotype following injection for COVID, especially in patients that got injected with mRNA.
Another recent study published in Cell found that the surge in heart failure being reported among children is a direct cause of mRNA "vaccination."
The latest news about injuries and deaths caused by COVID injections can be found at BadMedicine.news.
Sources for this article include:
Please contact us for more information.
